Graham Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
46,267
-6,160
-12% -$30.2K 0.01% 907
2026
Q1
$179K Sell
52,427
-106,412
-67% -$359K ﹤0.01% 969
2025
Q4
$450K Buy
158,839
+52,959
+50% +$273K 0.01% 664
2025
Q3
$737K Buy
105,880
+93,257
+739% +$658K 0.01% 468
2025
Q2
$74.7K Sell
12,623
-154,336
-92% -$888K ﹤0.01% 1229
2025
Q1
$1.07M Buy
166,959
+35,484
+27% +$342K 0.02% 530
2024
Q4
$1.56M Buy
131,475
+68,177
+108% +$1.16M 0.02% 369
2024
Q3
$1.75M Sell
63,298
-3,619
-5% -$90.5K 0.03% 316
2024
Q2
$1.6M Buy
66,917
+22,818
+52% +$536K 0.03% 294
2024
Q1
$776K Buy
+44,099
New +$650K 0.01% 489

Other funds holding ASPN

Graham Capital Management's ASPN Position: Q2 2026 in Review

Graham Capital Management reduced its Aspen Aerogels (ASPN) stake by 12% in Q2 2026, selling an estimated $30.2K and leaving 46,267 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #907.

Graham Capital Management first reported a position in ASPN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.75M in Q3 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Graham Capital Management held 46,267 shares of Aspen Aerogels worth $293K as of Q2 2026.
  • Graham Capital Management sold 6,160 Aspen Aerogels shares in Q2 2026, an estimated $30.2K.
  • Aspen Aerogels made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #907 holding.
  • Graham Capital Management first reported a position in Aspen Aerogels in Q1 2024 and has held it in 10 quarters since.
  • Graham Capital Management's Aspen Aerogels position peaked at $1.75M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.